SCHEMBL3638622

SCHEMBL3638622

CN(Cc1cc(C(F)(F)F)cc(C(F)(F)F)c1)C1CC(C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)N(Cc2ccccc2)C1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM4 P08173 1/20 0.47
ALDH1A1 P00352 4/20 0.47
MAPT P10636 4/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
POLB P06746 3/20 0.47
LMNA P02545 6/20 0.47
KMT2A Q03164 4/20 0.47
MEN1 O00255 2/20 0.45
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
HTT P42858 3/20 0.44
TSHR P16473 3/20 0.44
HPGD P15428 1/20 0.44
NR1H2 P55055 1/20 0.44
NR1H3 Q13133 1/20 0.44
KDM4E B2RXH2 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2817106 1.00 CHRM4 (0.47) CHRM4ALDH1A1MAPTSMN1; SMN2POLB
SCHEMBL2817840 0.94 POLB (0.44) CHRM4ALDH1A1MAPTSMN1; SMN2POLB
SCHEMBL3641058 0.94 KMT2A (0.41) CHRM4ALDH1A1MAPTSMN1; SMN2POLB
SCHEMBL2822473 0.94 KMT2A (0.41) CHRM4ALDH1A1MAPTSMN1; SMN2POLB
SCHEMBL2820467 0.94 LMNA (0.49) CHRM4ALDH1A1MAPTSMN1; SMN2POLB
SCHEMBL3979720 0.88 NPBWR1 (0.42) ALDH1A1MAPTSMN1; SMN2POLBLMNA
SCHEMBL2820035 0.87 TACR3 (0.44) CHRM4ALDH1A1SMN1; SMN2POLBLMNA
SCHEMBL3641111 0.87 TACR3 (0.44) CHRM4ALDH1A1SMN1; SMN2POLBLMNA
SCHEMBL3805658 0.86 LMNA (0.44) CHRM4ALDH1A1MAPTSMN1; SMN2POLB
SCHEMBL2822151 0.85 NPC1 (0.51) ALDH1A1SMN1; SMN2POLBLMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2155672-A1 PROLINAMIDE DERIVATIVES AS NK3 ANTAGONISTS F. Hoffmann-Roche AG (CH) 2010-02-24 EP claimed
WO-2008148689-A1 PROLINAMIDE DERIVATIVES AS NK3 ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2008-12-11 WO claimed
EP-2155672-A1 PROLINAMIDE DERIVATIVES AS NK3 ANTAGONISTS F. Hoffmann-Roche AG (CH) 2010-02-24 EP disclosed
WO-2008148689-A1 PROLINAMIDE DERIVATIVES AS NK3 ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2008-12-11 WO disclosed